Australia's most trusted
source of pharma news
Posted 28 July 2025 AM
So-called 'Ozempic face' - the sagging skin, tired appearance and wrinkles that can be a result of medication-driven weight loss - has led to the growth of a whole new market: the use of fillers and other treatments to plump up the faces of weight-loss patients.
As many as one in eight adults in the US has taken prescription weight-loss medication, and the number of prescriptions for these medications increased by more than 300 per cent between 2020 and 2022, according Balancing the Scales, a report by Switzerland-based pharma Galderma.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.